Tessera
Folgen

Daniel Erskine

@danielersk1ne.bsky.social

ARUK Senior Fellow and Senior Lecturer at Newcastle University. Interest in the neuropathology and biology of Lewy body diseases and related neurodegenerative diseases, particularly lysosomal storage disorders. Views are my own.

10 Posts214 Follower235 Folgt
The Dementia League@dementialeague.bsky.social · 2y ago

Early Possible Signs of Lewy Body Dementia:🔎 Start looking for early symptoms around ages 55-65, as LBD often develops between 50-85 years of age. 1️⃣ Cognitive changes: Fluctuating attention, alertness, or thinking ability ---

Daniel Erskine@danielersk1ne.bsky.social · 2y ago

Great editorial from Hubert Fernandez on an important paper led by @albertoespay.bsky.social, to which I contributed a small amount, on the role of aSyn in #Lewy body diseases. Open-mindedness is key, none of us have all the answers and we all have the same goal. www.prd-journal.com/article/S135...

The Alpha Synuclein Tug of War: A Call for Academic Civility and Open-mindedness

My dear colleagues, this month’s issue of Parkinsonism and Related Disorders features a Point of View paper by Espay et al entitled, “The α-Synuclein Seed Amplification Assay: Interpreting a Test of Parkinson’s Pathology” [1]. In this article, the authors caution those who jump on the synuclein bandwagon all too quickly. They present their viewpoints regarding the weaknesses of using alpha synuclein seed amplification assay (αSyn-SAA) as a basis for the biological staging of Parkinson disease (PD).

prd-journal.com